Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
UCB SA (UCB BB)
Watchlist
20
Analysis
Health Care
•
Belgium
UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Argenx SE
•
30 Aug 2024 23:40
Argenx SE (ARGX US): Vyvgart Indication Expansion Triggers Rally; Can Competition Play Spoilsport?
Argenx won FDA approval for second indication of Vyvgart for CIDP in June. Currently, Vyvgart dominates gMG treatment market. Competitor's drug...
Tina Banerjee
Follow
317 Views
Share
bearish
•
MSCI ACWI Index
•
23 Aug 2024 04:03
Shift Now to Defensives; Snap-Back Rally Testing Resistance $ACWI $SPX; Neutral Outlook Intact
Shift Now to Defensives (Health Care, Telecommunications, Utilities, and Consumer Staples); Snap-Back Rally Testing Resistance $ACWI $SPX; Neutral...
Vermilion Research
Follow
288 Views
Share
bullish
•
Novartis AG Reg
•
03 Aug 2024 04:30
Pullback Continues $ACWI; Stick With Defensives; More Countries With Improving Price and RS Trends
Pullback Continues $ACWI; Stick With Defensives. We continue to believe a 1- to 4-month pullback/consolidation is ongoing, and would look for an...
Vermilion Research
Follow
323 Views
Share
bullish
•
Samsung Biologics
•
02 Jul 2024 20:12
Samsung Biologics (207940 KS): Gaining Momentum on New Approval and Contract Wins; Hold Shares
Samsung Biologics signs $1.1B CMO contract, representing 40% of 2023 revenue. Samsung Bioepis receives FDA approval for Stelara biosimilar...
Tina Banerjee
Follow
317 Views
Share
bullish
•
SK Biopharmaceuticals
•
18 May 2024 01:29
SK Biopharmaceuticals (326030 KS): Resumption of US Sales Growth Raises Hope for Annual Profit
In 1Q24, SK Biopharmaceuticals posted Xcopri U.S. sales of KRW90.9B, up 69% YoY and 17% QoQ. The company remains confident to meet Xcopri annual...
Tina Banerjee
Follow
405 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.36.1
x